• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Healthcare·PR9.BK
Share

Praram 9 Hospital Public Company Limited Stocks

THB 17.9Last Updated 27.07.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

THB 415.13M

THB 17.9
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Praram 9 Hospital Public Company Limited manages Praram 9 Hospital, a prominent medical institution located in Thailand. This facility delivers a broad spectrum of tertiary healthcare services, encompassing health promotion, preventative medicine, thorough diagnosis, effective treatment, and comprehensive rehabilitation. Its core medical specialties include obstetrics and gynecology, general surgery, internal medicine, pediatrics, advanced kidney transplantation, cardiovascular care, and orthopedics. The hospital further distinguishes itself with numerous specialized centers, addressing areas such as diabetes and metabolic conditions, gastroenterology and hepatobiliary issues, neurological disorders, routine health check-ups, urgent care, physical therapy and rehabilitation, advanced imaging (radiology), ophthalmology, otolaryngology (ear, nose, and throat), dentistry, mental well-being, dermatology and cosmetic procedures, breast health, joint care, spinal conditions, allergy management, oncology, sleep disorders, pulmonary and respiratory diseases, wellness programs, and LASIK eye surgery. Established in 1992, the company maintains its primary base of operations in Bangkok, Thailand.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of PR9.BK is 24.6 and suggests 38.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

29.07.2026 14:27

SK hynix shares fell 10% following the announcement of a record quarter. What spooked the market?

29.07.2026 13:30

"There's a stock exchange, but virtually no capital market": Why $13 billion Was Withdrawn from Kazakhstan

29.07.2026 12:40

Oninvest Index: Space-Sector Small-Cap Stocks Have Lost Their Half-Year Gains. What's Next?

29.07.2026 12:08

Russia has issued an arrest warrant for Telegram founder Durov under a terrorism-related charge

29.07.2026 11:27

OpenAI Models Have Hacked a Second Company: What Will the Consequences Be?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026